Neurocrine Biosciences Inc
NBIX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000914475
In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Neurocrine Biosciences Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 513
- +61 vs. Q2 2023
- Shares held
- 91.8M
- +1.14M (+1.3%) vs. Q2 2023
- Total value
- $10.4B
- +$1.82B (+21.3%) vs. Q2 2023
- New holders
- 90
- 158 more added
- Sold out
- 29
- 198 more reduced
5 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 782 | $17.0B |
| Q1 2026 | 700 | $13.2B |
| Q4 2025 | 733 | $14.1B |
| Q3 2025 | 650 | $13.6B |
| Q2 2025 | 587 | $12.4B |
| Q1 2025 | 587 | $10.6B |
| Q4 2024 | 602 | $12.9B |
| Q3 2024 | 577 | $10.7B |
| Q2 2024 | 595 | $12.9B |
| Q1 2024 | 591 | $12.9B |
| Q4 2023 | 555 | $12.2B |
| Q3 2023 | 513 | $10.4B |
| Q2 2023 | 457 | $8.64B |
| Q1 2023 | 488 | $9.22B |
| Q4 2022 | 530 | $10.7B |
| Q3 2022 | 466 | $9.60B |
| Q2 2022 | 439 | $8.74B |
| Q1 2022 | 426 | $8.45B |
| Q4 2021 | 406 | $7.59B |
| Q3 2021 | 397 | $8.66B |
| Q2 2021 | 409 | $8.89B |
| Q1 2021 | 421 | $9.25B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Neurocrine Biosciences Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 1,268,266 | $142.7M | 0.15% | +418,008+49.2% | Added |
| Wellington Management Group LLP | 1,327,939 | $149.4M | 0.03% | −71,500−5.1% | Reduced |
| Bank of New York Mellon Corp | 1,539,392 | $173.2M | 0.04% | −49,823−3.1% | Reduced |
| Geode Capital Management, LLC | 1,554,630 | $174.7M | 0.02% | +31,222+2.0% | Added |
| Renaissance Technologies LLC | 1,590,164 | $178.9M | 0.31% | −53,238−3.2% | Reduced |
| Janus Henderson Group PLC | 1,717,054 | $193.2M | 0.13% | −191,790−10.0% | Reduced |
| JPMorgan Chase & Co | 1,811,237 | $203.8M | 0.02% | −150,637−7.7% | Reduced |
| Morgan Stanley | 1,924,079 | $216.5M | 0.02% | +56,054+3.0% | Added |
| Point72 Asset Management, L.P. | 2,578,128 | $290.0M | 0.99% | +2,466,770+2,215.2% | Added |
| Bellevue Group AG | 2,583,550 | $290.6M | 4.68% | −29,250−1.1% | Reduced |
| State Street Corp | 3,836,507 | $431.6M | 0.02% | −119,992−3.0% | Reduced |
| Vanguard Group Inc | 9,559,843 | $1.08B | 0.03% | −10,875−0.1% | Reduced |
| BlackRock Inc. | 13,371,398 | $1.50B | 0.04% | −110,744−0.8% | Reduced |
| TD Ameritrade Investment Management, LLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −71,770−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −17,341−100.0% | Sold out |
| L2 Asset Management, LLC | 0 | $0 | 0.00% | −15,625−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −11,347−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −6,945−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −6,430−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −5,353−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −4,839−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −4,745−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −4,481−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −4,340−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −4,214−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −3,937−100.0% | Sold out |
| Donoghue Forlines LLC | 0 | $0 | 0.00% | −3,174−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −3,024−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −2,298−100.0% | Sold out |
| Perpetual Ltd | 0 | $0 | 0.00% | −2,268−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −472−100.0% | Sold out |
| V-Square Quantitative Management LLC | 0 | $0 | 0.00% | −143−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Safeguard Financial, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| 25 LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Abound Wealth Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |
| EA Series Trust | – | – | – | – | Not filed |
| Efg Capital International Corp. | – | – | – | – | Not filed |
| Piershale Financial Group, Inc. | – | – | – | – | Not filed |